We are live on
!
Find out more
SC
Scholtz & Company Portfolio holdings
AUM
$195M
1-Year Est. Return
12.04%
This Fund
S&P 500
This Quarter
Est. Return
+9.77%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$141M
AUM Growth
+$1.24M
(+0.89%)
Cap. Flow
+$1.1M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
65.29%
Holding
52
New
6
Increased
8
Reduced
31
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Short S&P500
SH
|
+$7.8M |
| 2 |
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
|
+$1.17M |
| 3 |
ProShares Short QQQ
PSQ
|
+$1.07M |
| 4 |
Northrop Grumman
NOC
|
+$900K |
| 5 |
W.R. Berkley
WRB
|
+$691K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.69M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.48M |
| 3 |
ProShares Short High Yield
SJB
|
+$1.31M |
| 4 |
Air Products & Chemicals
APD
|
+$1.13M |
| 5 |
Zoetis
ZTS
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.78% |
| 3 | Consumer Discretionary | 16.97% |
| 4 | Industrials | 15.55% |
| 5 | Financials | 11.31% |
Similar funds
HAS
MHFA
TF
RAM
ICMARC
CPRPA
WAL
CPI
Scholtz & Company's Q4 2022 Portfolio in Review
As of Q4 2022, Scholtz & Company held 52 positions worth $141M, up 0.89% from $140M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Scholtz & Company's Q4 2022 filing shows 6 new, 8 increased, 31 reduced and 7 closed positions. Its largest new stake was ProShares Short S&P500: 121,683 shares worth $7.8M. The largest sale was Lam Research, an estimated $1.69M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Scholtz & Company's largest Q4 2022 buy was ProShares Short S&P500: 121,683 shares worth $7.8M.
- Scholtz & Company added most to Northrop Grumman in Q4 2022, an estimated $900K increase.
- Scholtz & Company's biggest Q4 2022 reduction was ProShares Short High Yield, cutting an estimated $1.31M.
- Scholtz & Company fully exited Lam Research in Q4 2022, selling an estimated $1.69M.
- Scholtz & Company's ten largest holdings make up 65% of its $141M portfolio in Q4 2022.
- Scholtz & Company opened 6 new positions and closed 7 in Q4 2022.
- Scholtz & Company's portfolio value rose 0.89% quarter-over-quarter to $141M.
Based on Scholtz & Company's 13F filing for Q4 2022, filed 14 Feb 2023.